Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis
Authors:
- Melanie BaenschMBMelanie Baensch
- Wilfried BautschWBWilfried Bautsch
- Meike HenneckeMHMeike Hennecke
- Andreas KlosAKAndreas Klos
- Monika CasarettoMCMonika Casaretto
- Jörg KohlJKJörg Kohl
- 1 June 1996
- journal article
- Published by Elsevier in Immunotechnology
- Vol. 2 (2) , 115-126
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Arginine 206 of the C5a Receptor Is Critical for Ligand Recognition and Receptor Activation by C-terminal Hexapeptide AnalogsJournal of Biological Chemistry, 1995
- Characterization of phage that bind plastic from phage-displayed random peptide librariesGene, 1995
- Complement Activation and Polymorphonuclear Neutrophil Leukocyte Elastase in SepsisArchives of Surgery, 1992
- Human C5a Anaphylatoxin: Gene Cloning and Expression in Escherichia coliImmunobiology, 1992
- Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cellsBiochemistry, 1991
- Further studies on the use of multi-substituted benzenesulfonyl groups for protection of the guanidino function of arginine.Chemical and Pharmaceutical Bulletin, 1981
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidaseJournal of Clinical Investigation, 1970
- 9-Fluorenylmethoxycarbonyl function, a new base-sensitive amino-protecting groupJournal of the American Chemical Society, 1970
- THE DERIVATION OF TWO DISTINCT ANAPHYLATOXIN ACTIVITIES FROM THE THIRD AND FIFTH COMPONENTS OF HUMAN COMPLEMENTJournal of Experimental Medicine, 1968